Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adcetris in High Risk Pediatric Hodgkin Lymphoma
NCT01920932Phase 2Active, not recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Aug 2013
- Primary completion
- Nov 2020
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brentuximab vedotin in Hodgkin lymphoma (HL), sponsored by St. Jude Children's Research Hospital. Started Aug 2013; status: active, not recruiting.
02
Drugs
brentuximab vedotin
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01920932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01920932.